Oticara Reports Positive Phase 2 Results for Novel Nasal Cream in Chronic Rhinosinusitis

Oticara’s Novel Steroid Nasal Cream Shows Promising Phase 2 Results in Post-Surgical Chronic Rhinosinusitis Patients Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced highly encouraging Phase 2 results for its proprietary steroid nasal…










